Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-19T15:28:11.390Z Has data issue: false hasContentIssue false

Evaluación de la apatía: uso de la Escala de Evaluación de la Apatía en el primer episodio de psicosis

Published online by Cambridge University Press:  01 April 2008

Ana Faerden
Affiliation:
Sección para la Investigación de la Psicosis, División de Psiquiatría, Edificio 49, Hospital Universitario Ullevåll, Krikeveien 166, 0407Oslo, Noruega
Ragnar Nesvåg
Affiliation:
Hospital Diakonhjemmet, 0319Oslo, Noruega
Elizabeth Ana Barrett
Affiliation:
Hospital Universitario Aker, 0514Oslo, Noruega
Ingrid Agartz
Affiliation:
Hospital Diakonhjemmet, 0319Oslo, Noruega Instituto de Psiquiatría, Universidad de Oslo, 0318Oslo, Noruega
Arnstein Finset
Affiliation:
Instituto de Ciencias del Comportamiento en Medicina, Universidad de Oslo, 0317Oslo, Noruega
Svein Friis
Affiliation:
Sección para la Investigación de la Psicosis, División de Psiquiatría, Edificio 49, Hospital Universitario Ullevåll, Krikeveien 166, 0407Oslo, Noruega Instituto de Psiquiatría, Universidad de Oslo, 0318Oslo, Noruega
Jan Ivar Rossberg
Affiliation:
Sección para la Investigación de la Psicosis, División de Psiquiatría, Edificio 49, Hospital Universitario Ullevåll, Krikeveien 166, 0407Oslo, Noruega Instituto de Psiquiatría, Universidad de Oslo, 0318Oslo, Noruega
Ingrid Melle
Affiliation:
Sección para la Investigación de la Psicosis, División de Psiquiatría, Edificio 49, Hospital Universitario Ullevåll, Krikeveien 166, 0407Oslo, Noruega Instituto de Psiquiatría, Universidad de Oslo, 0318Oslo, Noruega
Get access

Resumen

Antecedentes.

Recientemente ha aumentado el interés por definir los límites y subdominios del síndrome negativo de la esquizofrenia y se han buscado nuevas escalas. La apatía es uno de los síntomas analizados. La Escala de Evaluacion de la Apatía (AES) con su version clínica (AES-C) es una de las escalas más usada en un contexto interdisciplinario, pero no se ha usado antes en poblaciones con el primer episodio de psicosis. Los objetivos principales de este estudio fueron examinar las propiedades psicométricas de la AES-C y su relación con la Escala de Síndrome Positiva y Negativa (PANSS).

Métodos.

Se incluyeron 104 pacientes con un primer episodio de psicosis del estudio de Investigación Tematicá Organizada de la Psicosis (TOP).

Resultados.

En el análisis de los factores de la AES-C se identificaron tres subescalas: Apatía, Percepción y Contactos Sociales. Sólo la subescala de Apatía exhibió propiedades psicométricas satisfactorias y propiedades convergentes y discriminatorias aceptables por correlación fuerte con los apartados del PANSS relacionados con la apatía.

Conclusiones.

Este estudio demuestra que la AES-C mide mas de una dimensión. Sin embargo, el factor principal, la subescala de la Apatía, puede usarse para evaluar la apatía en pacientes con un primer episodio de psicosis con el fin de refinar la evalaución de los subdominios del síndrome negativo.

Type
Artículo original
Copyright
Copyright © European Psychiatric Association 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografia

[1]Altamura, ACBassetti, RSassella, FSalvadori, DMundo, E. Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study. Schizophr Res 2001; 52(1-2):2936.CrossRefGoogle ScholarPubMed
[2] American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM IV. 4th ed. Washington DC: American Psychiatric Association; 1994.Google Scholar
[3]Andersson, SKrogstad, JMFinset, A. Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reaction. Psychol Med 1999; 29(2): 447-56.CrossRefGoogle Scholar
[4]Andreasen, NC. Schizophrenia: Positive and negative symptoms and syndromes. Basel: Modern Problems of Pharmocopsychiatry; 1990.Google Scholar
[5]Baudic, SMaison, PDolbeau, GBoisse, MFBartolomeo, PDalla, BG, et al. Cognitive impairment related to apathy in early Huntington’s disease. Dement Geriatr Cogn Disord 2006; 21 (5-6): 316-21.CrossRefGoogle ScholarPubMed
[6]Blanchard, JJCohen, AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull 2005 Oct 27.Google Scholar
[7]Bleuler, E. Dementia preacox or the group of schizophrenias. New York: International Universities Press; 1950.Google Scholar
[8]Bower, FLMcCullough, CSPille, BL. Synthesis of research findings regarding Alzheimer’s disease: part III, Caregiver burden and care settings. Online J Knowl Synth Nurs 2002; 9: 5.Google ScholarPubMed
[9]Clarke, DEReekum, RSimard, MStreiner, DLFreedman, MConn, D. Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci 2007; 19( 1 ): 5764.CrossRefGoogle ScholarPubMed
[10]Cummings, JLMega, MGray, KRosenberg-Thompson, SCarusi, DAGornbein, J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44(12): 2308-14.CrossRefGoogle ScholarPubMed
[11]Earnst, KSKring, AM. Construct validity of negative symptoms: an empirical and conceptual review. Clin Psychol Rev 1997; 17(1): 167-89.CrossRefGoogle ScholarPubMed
[12]Emsley, RRabinowitz, JTorreman, M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res 2003; 61(l): 4757.CrossRefGoogle Scholar
[13]Erhart, SMMarder, SRCarpenter, WT. Treatment of schizophrenia negative symptoms: future prospects. Schizophr Bull 2006; 32(2): 234-7.CrossRefGoogle ScholarPubMed
[14]Finset, AAndersson, S. Coping strategies in patients with acquired brain injury: relationships between coping, apathy, depression and lesion location. Brain Inj 2000; 14(10): 887905.Google ScholarPubMed
[15]Jones, SHThornicroft, GCoffey, MDunn, G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry 1995; 166(5): 654-9.CrossRefGoogle Scholar
[16]Kalechstein, ADNewton, TF, Leavengood AF1. Apathy syndrome in cocaine dependence. Psychiatry Res 2002; 109( 1): 97100.CrossRefGoogle ScholarPubMed
[17]Kay, SRFiszbein, AOpler, LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13(2): 261-76.CrossRefGoogle Scholar
[18]Kiang, MChristensen, BKRemington, GKapur, S. Apathy in schizophrenia: clinical correlates and association with functional outcome. Schizophr Res 2001; 63(l-2): 7988.CrossRefGoogle Scholar
[19]Kirkpatrick, BFenton, WSWT, Carpenter JrMarder, SR. The NIMHMATRICS consensus statement on negative symptoms. Schizophr Bull 2006; 32(2): 214-9.CrossRefGoogle ScholarPubMed
[20]Kirsch-Darrow, LFernandez, HHMarsiske, MOkun, MSBowers, D. Dissociating apathy and depression in Parkinson disease. Neurology 2006; 67(l): 33-8.CrossRefGoogle ScholarPubMed
[21]Kraepelin, E. Repnnt 1919 English translated edition. In: Robert, E, editor. Dementia praecox and paraphrenia. Fluntington. New York: Krieger Publishing Co Inc.; 1971.Google Scholar
[22]Lueken, USeidl, UVolker, LSchweiger, EKruse, ASchroder, J. Development of a short version of the Apathy Evaluation Scale specifically adapted for demented nursing home residents. Am J Geriatr Psychiatry 2007; 15(5): 376-85.CrossRefGoogle Scholar
[23]Malla, AKTakhar, JJNorman, RMManchanda, RCortese, LHaricharan, R, et al. Negative symptoms in first episode non-affective psychosis. Acta Psychiatr Scand 2002; 105(6): 431-9.CrossRefGoogle ScholarPubMed
[24]Marin, RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991;3(3):243-54.Google ScholarPubMed
[25]Marin, RSBiedrzycki, RCFirinciogullari, S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991;38(2): 143-62.CrossRefGoogle ScholarPubMed
[26]Marin, RSFogel, BSFlawkins, JDuffy, JKrupp, B. Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 1995; 7(l): 2330.Google ScholarPubMed
[27]Moller, HJBottlender, RGross, AHoff, PWittmann, JWegner, U, et al. The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophr Res 2002; 56(1-2): 8794.CrossRefGoogle ScholarPubMed
[28]Overail, JEGorham, DR. The Brief Psychiatric rating Scale (BPRS): recent development in ascertainment and scaling. Psychopharmacol Bull 1988; 24: 97-9.Google Scholar
[29]Peralta, VCuesta, MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues Influencing their ascertainment. Schizophr Res 2001; 49(3): 269-85.CrossRefGoogle ScholarPubMed
[30]Richard, IH. Apathy does not equal depression in Parkinson disease: why we should care. Neurology 2006; 67(1): 10-1.CrossRefGoogle Scholar
[31]Robert, PHClairet, SBenoit, MKoutaich, JBertogliati, CTibie, O, et al. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry 2002; 17( 12): 1099-105.CrossRefGoogle ScholarPubMed
[32]Robert, PHVerhey, FRByrne, EJHurt, C, De Deyn PP, Nobili F, et al. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry 2005; 20(7): 490-6.Google ScholarPubMed
[33]Sellen, JP, van de Wiersma D. Distress attributed to negative symptoms in schizophrenia. Schizophr Bull 2000; 26(3): 737-44.Google Scholar
[34]Starkstein, SEPetracca, GChemerinski, EKremer, J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001; 158(6): 872-7.CrossRefGoogle ScholarPubMed
[35]Stout, JCReady, REGrate, JMalloy, PFPaulsen, JS. Factor analysis of the frontal Systems behavior scale (FrSBe). Assessment 2003; 10(1): 7985.CrossRefGoogle Scholar
[36]Toomey, RKremen, WSSimpson, JCSamson, JASeidman, LJLyons, MJ, et al. Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients. Am J Psychiatry 1997; 154(3): 371-7.Google ScholarPubMed
[37]van Reekum, RStuss, DTOstrander, L. Apathy: why care? J Neuropsychiatry Clin Neurosci 2005; 17(1): 719.CrossRefGoogle ScholarPubMed
[38]Ventura, JLiberman, RPGreen, MFShaner, AMintz, J. Training and quality assurance with the Structured Clinical Interview for DSMIV (SCID-I/P). Psychiatry Res 1998; 79(2): 163-73.CrossRefGoogle Scholar
[39]Ventura, JNuechterlein, KHSubotnik, KLGutkind, DGilbert, EA. Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res 2000; 97(2-3): 129-35.CrossRefGoogle ScholarPubMed
[40]Yung, ARPhillips, LJYuen, HPFrancey, SMMcFarlane, CAHallgren, M, et al. Psychosis prediction: 12-month follow up of a highrisk ("prodromal") group. Schizophr Res 2003; 60(1): 2132.CrossRefGoogle Scholar